Importantly, overexpression of Lrp4 and MuSK in HCC tumours (8 out of 11 HCC patients; Supplementary Fig. 14d) is consistent with the notion that Agrin functions through the Lrp4–MuSK complex to activate FAK in driving the oncogenic programme of HCC cells. The gene discussed is PTK2; the disease is neoplasm.